The human immunodeficiency virus continuum of care in European Union Countries in 2013: Data and Challenges

Annabelle Gourlay, Teymur Noori, Anastasia Pharris, Maria Axelsson, Dominique Costagliola, Susan Cowan, Sara Croxford, Antonella D'arminio Monforte, Julia Del Amo, Valerie Delpech, Asunción Díaz, Enrico Girardi, Barbara Gunsenheimer-Bartmeyer, Victoria Hernando, Sophie Jose, Gisela Leierer, Georgios Nikolopoulos, Niels Obel, Eline Op De Coul, Dimitra ParaskevaPeter Reiss, Caroline Sabin, André Sasse, Daniela Schmid, Anders Sonnerborg, Alexander Spina, Barbara Suligoi, Virginie Supervie, Giota Touloumi, Dominique Van Beckhoven, Ard Van Sighem, Georgia Vourli, Robert Zangerle, Kholoud Porter

Research output: Contribution to journalArticle

Abstract

Background. The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set a "90-90-90" target to curb the human immunodeficiency virus (HIV) epidemic by 2020, but methods used to assess whether countries have reached this target are not standardized, hindering comparisons. Methods. Through a collaboration formed by the European Centre for Disease Prevention and Control (ECDC) with European HIV cohorts and surveillance agencies, we constructed a standardized, 4-stage continuum of HIV care for 11 European Union countries for 2013. Stages were defined as (1) number of people living with HIV in the country by end of 2013; (2) proportion of stage 1 ever diagnosed; (3) proportion of stage 2 that ever initiated ART; and (4) proportion of stage 3 who became virally suppressed (≤200 copies/mL). Case surveillance data were used primarily to derive stages 1 (using back-calculation models) and 2, and cohort data for stages 3 and 4. Results. In 2013, 674500 people in the 11 countries were estimated to be living with HIV, ranging from 5500 to 153400 in each country. Overall HIV prevalence was 0.22% (range, 0.09%-0.36%). Overall proportions of each previous stage were 84% diagnosed, 84% on ART, and 85% virally suppressed (60% of people living with HIV). Two countries achieved ≥90% for all stages, and more than half had reached ≥90% for at least 1 stage. Conclusions. European Union countries are nearing the 90-90-90 target. Reducing the proportion undiagnosed remains the greatest barrier to achieving this target, suggesting that further efforts are needed to improve HIV testing rates. Standardizing methods to derive comparable continuums of care remains a challenge.

Original languageEnglish
Pages (from-to)1644-1656
Number of pages13
JournalClinical Infectious Diseases
Volume64
Issue number12
DOIs
Publication statusPublished - Jun 15 2017

Keywords

  • antiretroviral therapy.
  • cohort analysis
  • continuum of care
  • HIV infection
  • surveillance

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'The human immunodeficiency virus continuum of care in European Union Countries in 2013: Data and Challenges'. Together they form a unique fingerprint.

  • Cite this

    Gourlay, A., Noori, T., Pharris, A., Axelsson, M., Costagliola, D., Cowan, S., Croxford, S., D'arminio Monforte, A., Del Amo, J., Delpech, V., Díaz, A., Girardi, E., Gunsenheimer-Bartmeyer, B., Hernando, V., Jose, S., Leierer, G., Nikolopoulos, G., Obel, N., Op De Coul, E., ... Porter, K. (2017). The human immunodeficiency virus continuum of care in European Union Countries in 2013: Data and Challenges. Clinical Infectious Diseases, 64(12), 1644-1656. https://doi.org/10.1093/cid/cix212